Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (96780)	3/18/2000 8:33:00 AM
From: Sam Sara	Read Replies (1) \| Respond to of 164684

I am still puzzling over reaction to Clinton/Blair statement- perhaps the best interpretation is that this was a premier example of how little momentum investors (and I include myself in this class at times) look into real picture. Heck, you can go get vast amounts of sequence information for free (http://gdbwww.gdb.org/), and that has been the case for years and years. The real questions are very different- it is clear that there will be major advances due to genetic analysis/manipulation, but it is not so clear to me where the real impact will be. On the human side, key is to find tests/treatments for prevalent diseases/problems to be massively profitable e.g. obesity, hypertension, if you are a pure pharmaceutical company. Enabling technology companies should also do well, but the growth curve here is nowhere near the curve of something like the internet. Also, I hear very little about agricultural/animal applications, as well as industrial applications, perhaps because of the current poor political climate for these applications. In the long run, these should be very large. For the B&H type, this seems like a good entry point. The problem (for me) is that there are so many stocks out there that are appreciating right now, and my crystal ball does not tell me what BBH is going to do over the next few months. Charts suggest some basing is in order. I have taken my lumps (I thought I was being smart buying at 21 day MA area, but that did was not strong support, to say the least) in biotech, so have scaled back exposure, only to free up funds for stocks I think have more near-term potential. I still have a good chunk in biotech, since I think story has not been changed one iota by Clinton/Blair announcement. That was a nonevent that created a buying opportunity for the patient.